Denosumab promising in GCT

12 February 2010 | by Nicola Garrett Print this article Comments Share this article
The monoclonal antibody denosumab may be a promising treatment in some patients with inoperable giant-cell tumour (GCT) of bone, research shows....

Want to read complete article? Please Sign in or Register.

Most viewed articles this week

Recent comments

Related sites